BLFS

MKT CAP:$1B

BioLife Solutions, Inc.

Market Cap

$1B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$23.11-$0.78 (-3.26%)

Apr 22, 2026

Company Details

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products ...

CEO

Roderick de Greef

IPO Date

Nov 22, 1989

Website

www.biolifesolutions.com

Key Metrics TTM

Revenue

$74M

-6.5% YoY

Net Income

-$3M

EPS (Diluted)

-$0.07

Free Cash Flow

$11M

Revenue / Share

$1.52

Gross Margin

78.0%

Operating Margin

-22.4%

Net Margin

-4.3%

FCF Margin

14.3%

P/S

14.1x

P/E

—

Earnings Reports

Q4 2025

May 14, 2026

PENDING

Q3 2025

Nov 6, 2025

$28MEPS $0.01

Q2 2025

Aug 7, 2025

$25M+28.9%EPS -$0.33

Q1 2025

May 8, 2025

$24M+29.9%EPS -$0.01

FY 2024

Mar 3, 2025

$82M+8.4%EPS -$0.44

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 21	$17M	$9M	-$981.0K
Q2 21	$31M	$13M	-$5M
Q3 21	$34M	$9M	-$11M
Q1 22	$36M	$12M	-$11M
Q2 22	$41M	$14M	-$9M
Q3 22	$41M	$14M	-$9M
Q1 23	$38M	$14M	-$13M
Q2 23	$40M	$12M	-$15M
Q3 23	$24M	$12M	-$9M
Q4 23	$17M	$9M	-$7M
Q1 24	$18M	$12M	-$3M
Q2 24	$20M	$13M	-$4M
Q4 24	-$3M	$8M	$1M
Q1 25	$24M	$16M	-$1M
Q2 25	$25M	$16M	-$17M
Q3 25	$28M	$17M	-$89.0K

Valuation

Quarter	P/S	P/E
Q1 21	19.7x	—
Q2 21	14.1x	297.7x
Q3 21	10.8x	221.1x
Q1 22	8.8x	—
Q2 22	7.3x	—
Q3 22	6.9x	—
Q1 23	6.7x	—
Q2 23	6.6x	—
Q3 23	7.4x	—
Q4 23	8.8x	—
Q1 24	10.5x	—
Q2 24	13.2x	—
Q4 24	20.0x	—
Q1 25	17.7x	—
Q2 25	15.9x	—
Q3 25	14.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 21	$2M	-$572.0K
Q2 21	-$8M	-$10M
Q3 21	$2M	-$329.0K
Q1 22	-$8M	-$9M
Q2 22	-$10M	-$12M
Q3 22	$1M	-$950.0K
Q1 23	-$3M	-$6M
Q2 23	-$8M	-$8M
Q3 23	-$4M	-$6M
Q4 23	$2M	$1M
Q1 24	-$4M	-$5M
Q2 24	$6M	$5M
Q4 24	$2M	$583.0K
Q1 25	$2M	$2M
Q2 25	$7M	$6M
Q3 25	$6M	$3M

Capital Expenditures

Quarter	CapEx
Q1 21	$2M
Q2 21	$2M
Q3 21	$2M
Q1 22	$1M
Q2 22	$2M
Q3 22	$2M
Q1 23	$3M
Q2 23	$609.0K
Q3 23	$1M
Q4 23	$981.0K
Q1 24	$356.0K
Q2 24	$995.0K
Q4 24	$1M
Q1 25	$175.0K
Q2 25	$2M
Q3 25	$3M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 21	+38.5%	+51.2%
Q2 21	+214.6%	+262.1%
Q3 21	+199.7%	+259.0%
Q1 22	+146.0%	+142.4%
Q2 22	+140.6%	+176.3%
Q3 22	+30.6%	+39.3%
Q1 23	+11.5%	+12.5%
Q2 23	+9.1%	+16.1%
Q3 23	-41.8%	-34.4%
Q4 23	-57.3%	-50.1%
Q1 24	-51.1%	-57.0%
Q2 24	-50.1%	-57.3%
Q4 24	-114.5%	-114.9%
Q1 25	+37.7%	+1.3%
Q2 25	+37.9%	+93.6%
Q3 25	+42.4%	+20.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 21	$2M	8.9%
Q2 21	$3M	8.1%
Q3 21	$5M	14.4%
Q1 22	$5M	14.9%
Q2 22	$6M	14.7%
Q3 22	$6M	15.5%
Q1 23	$7M	19.5%
Q2 23	$7M	17.4%
Q3 23	$9M	38.7%
Q4 23	$8M	47.9%
Q1 24	$6M	33.5%
Q2 24	$9M	44.2%
Q4 24	$11M	—
Q1 25	$4M	17.3%
Q2 25	$6M	23.0%
Q3 25	$6M	21.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 21	$2M	$5M	$2M
Q2 21	$3M	$7M	$3M
Q3 21	$3M	$10M	$4M
Q1 22	$4M	$11M	$5M
Q2 22	$3M	$11M	$5M
Q3 22	$3M	$12M	$5M
Q1 23	$4M	$15M	$6M
Q2 23	$5M	$15M	$6M
Q3 23	$5M	$13M	$5M
Q4 23	$4M	$13M	$5M
Q1 24	$4M	$10M	$2M
Q2 24	$2M	$9M	$2M
Q4 24	$1M	$7M	—
Q1 25	$2M	$12M	$3M
Q2 25	$3M	$11M	$3M
Q3 25	$3M	$12M	$3M

Revenue Segments

Quarter	Product	Rental Revenue	Service
Q1 25	$22M	$2M	$60.0K
Q2 25	$24M	$2M	$36.0K
Q3 25	$26M	$2M	$26.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$59M	$0	$59M
Q2 22	$24M	$23M	$47M
Q3 22	$27M	$35M	$62M
Q4 22	$19M	$43M	$63M
Q1 23	$19M	$36M	$55M
Q2 23	$21M	$25M	$46M
Q3 23	$19M	$22M	$41M
Q4 23	$28M	$16M	$44M
Q1 24	$30M	$16M	$45M
Q2 24	$22M	$12M	$34M
Q3 24	$24M	$10M	$34M
Q4 24	$95M	$9M	$105M
Q1 25	$67M	$22M	$89M
Q2 25	$32M	$50M	$82M
Q3 25	$29M	$49M	$79M
Q4 25	$33M	$56M	$89M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 21	33M	+0.8%	+58.2%
Q2 21	40M	+21.5%	+73.4%
Q3 21	43M	+7.2%	+36.8%
Q1 22	42M	-3.0%	+27.5%
Q2 22	42M	+1.1%	+27.8%
Q3 22	43M	+0.4%	+5.6%
Q1 23	43M	+0.9%	-0.6%
Q2 23	43M	+1.0%	+3.4%
Q3 23	44M	+0.3%	+2.6%
Q4 23	45M	+2.9%	+5.1%
Q1 24	45M	+1.4%	+5.6%
Q2 24	46M	+1.3%	+5.9%
Q4 24	48M	+4.4%	+10.2%
Q1 25	47M	-1.9%	+5.2%
Q2 25	48M	+1.4%	+5.2%
Q3 25	49M	+1.9%	+5.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 21	$87.3K	193
Q2 21	$161.7K	193
Q3 21	$175.1K	193
Q1 22	$83.8K	432
Q2 22	$93.8K	432
Q3 22	$94.3K	432
Q1 23	$80.9K	466
Q2 23	$84.8K	466
Q3 23	$50.6K	466
Q4 23	$42.5K	409
Q1 24	$45.1K	409
Q2 24	$48.2K	409
Q4 24	-$72.9K	47
Q1 25	$509.4K	47
Q2 25	$540.9K	47
Q3 25	$597.2K	47

Revenue / Employee